Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment-Reference-Cited by-同舟云学术

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment

Published:2018 Issue:1 Volume:16 Page:4
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Park Dong Il¹,Hisamatsu Tadakazu²,Chen Minhu³,Ng Siew Chien⁴,Ooi Choon Jin⁵,Wei Shu Chen⁶,Banerjee Rupa⁷,Hilmi Ida Normiha⁸,Jeen Yoon Tae⁹,Han Dong Soo¹⁰,Kim Hyo Jong¹¹,Ran Zhihua¹²,Wu Kaichun¹³,Qian Jiaming¹⁴,Hu Pin-Jin³,Matsuoka Katsuyoshi¹⁵,Andoh Akira¹⁶,Suzuki Yasuo¹⁷,Sugano Kentaro¹⁸,Watanabe Mamoru¹⁵,Hibi Toshifumi¹⁹,Puri Amarender S.²⁰,Yang Suk-Kyun²¹

Affiliation:

1. Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. The Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

3. Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

4. Department of Medicine and Therapeutics, Institute of Digestive Disease, LKS Institute of Health Science, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

5. Gleneagles Medical Centre and Duke-NUS Medical School, Singapore, Singapore.

6. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

7. Department of Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.

8. Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

9. Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

10. Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea.

11. Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.

12. Department of Gastroenterology, Shanghai Jiao Tong University, Shanghai, China.

13. Department of Gastroenterology, Fourth Military Medical University, Xi'an, China.

14. Department of Gastroenterology, Peking Union Medical College, Beijing, China.

15. Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.

16. Department of Gastroenterology, Shiga University, Otsu, Japan.

17. Department of Internal Medicine, Toho University, Sakura, Japan.

18. Department of Medicine, Jichi Medical University, Shimotsuke, Japan.

19. Center for Advanced IBD Research and Treatment, Kitasato University, Tokyo, Japan.

20. Department of Gastroenterology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India.

21. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

Ministry of Health and Welfare

Publisher

Korean Association for the Study of Intestinal Diseases

Subject

Gastroenterology

Link

https://synapse.koreamed.org/pdf/10.5217/ir.2018.16.1.4

Reference90 articles.

1. Latent Mycobacterium tuberculosis Infection

2. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

3. Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation

4. TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection

5. Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis risk in patients with Crohn’s disease on biologics: a retrospective analysis of the Japanese Medical Claims Database;Intestinal Research;2024-08-19

2. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review;Clinical Microbiology and Infection;2024-08

3. Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease;Journal of Gastroenterology and Hepatology;2024-05-09

4. Crohn’s disease and intestinal tuberculosis: challenging from every angle;BMJ Case Reports;2023-12

5. Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis;Cureus;2023-09-17